ARCHIVES

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

DeVita Emphasizes NCI Prevention In Statement To Senate Committee

February 15, 1980

Cancergrams Cost $840 Year For All

December 2, 1977

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

In Brief: Tipping Resigns Forom ACS; Vaughan Joins UAB BMT Program; PCI Recruits Ball, Finn, Mirro

September 20, 1991

Quality of Care: ASCO Publishes “Top Five” Ways to Improve Cancer Care

November 1, 2013

U.S. Radiologists Criticize Canadian Study Of Mammography Screening Showing No Benefit

November 27, 1992